BioCentury
ARTICLE | Clinical News

Saronic preclinical data

March 7, 2016 8:00 AM UTC

In a mouse model of HCC, SBI1997 led to a 60-day survival rate of 90% vs. 5% for untreated controls. Additionally, non-invasive bioluminescence imaging showed visible tumor regression in SBI1997-treat...